Back to Authors

Rafferty, Mark

A5111593500 | I2800373718

Mayo Clinic

Beatson West of Scotland Cancer Centre

Citations 2

P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e7796003

10.1097/01.hs9.0000970972.77960.03

Avapritinib versus Placebo in Indolent Systemic Mastocytosis

NEJM Evidence | May 23, 2023 | Volume: 2 | Issue: 6 | Pages: No page available

10.1056/evidoa2200339 | PMID 38320129